TTD Drug ID: DNC000364

Drug Information
Name	BW A4C
Indication	Not Available			Experimental
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C17H17NO3/c1-14(19)18(20)12-6-8-15-7-5-11-17(13-15)21-16-9-3-2 -4-10-16/h2-11,13,20H,12H2,1H3/b8-6+
InChIKey	CEUDWZXMLMKPNN-SOFGYWHQSA-N
Canonical SMILES	CC(=O)N(CC=CC1=CC(=CC=C1)OC2=CC=CC=C2)O
Isomeric SMILES	CC(=O)N(C/C=C/C1=CC(=CC=C1)OC2=CC=CC=C2)O
CAS Number	CAS 106328-57-8
PubChem Compound ID	CID 6438354.
PubChem Substance ID	SID 700722.
Target	Arachidonate 5-lipoxygenase			Inhibitor	[1][2][3][2]
Ref 1	Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas. Oncogene. 2009 Jul 23;28(29):2690-6. Epub 2009 Jun 8. To Reference
Ref 2	Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions. 1991 Mar;32(3-4):289-94. To Reference
Ref 3	Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.